Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Novotech
Explore 16 clinical trials worldwide
Search
Showing 1-16 of 16 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Novotech
Clinical Trials (16)
NCT07219771
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients
PHASE3
Recruiting
260 participants
Started: Oct 14, 2025 · Completed: Oct 31, 2027
1 condition
2 sponsors
9 locations
NCT06961565
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
PHASE1
Recruiting
56 participants
Started: May 30, 2025 · Completed: Dec 31, 2027
5 conditions
2 sponsors
4 locations
NCT06429930
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
PHASE1
Recruiting
56 participants
Started: Apr 11, 2025 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06717100
Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib
PHASE1
Not yet recruiting
30 participants
Started: Dec 31, 2024 · Completed: Mar 31, 2025
1 condition
2 sponsors
0 locations
NCT06523153
A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants
PHASE1
Active, not recruiting
40 participants
Started: Aug 28, 2024 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT06557499
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
NA
Recruiting
600 participants
Started: Aug 23, 2024 · Completed: May 19, 2025
1 condition
2 sponsors
3 locations
NCT06183671
JX09 SAD/MAD in Healthy Participants
PHASE1
Recruiting
92 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05957081
Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
PHASE1
Not yet recruiting
67 participants
Started: Nov 28, 2023 · Completed: Oct 4, 2028
1 condition
3 sponsors
4 locations
NCT05951049
A Study of AT-02 in Subjects With Systemic Amyloidosis.
PHASE2
Recruiting
120 participants
Started: Sep 21, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
4 locations
NCT05876312
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
PHASE1/PHASE2
Recruiting
50 participants
Started: Aug 7, 2023 · Completed: Sep 30, 2026
1 condition
3 sponsors
4 locations
NCT05762276
A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants
PHASE1
Active, not recruiting
64 participants
Started: Mar 7, 2023 · Completed: Jun 27, 2024
1 condition
2 sponsors
5 locations
NCT05521022
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
PHASE1
Recruiting
100 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
1 condition
2 sponsors
11 locations
NCT05456724
A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Aug 4, 2022 · Completed: Jul 31, 2024
2 conditions
2 sponsors
1 location
NCT05288543
A Study of Orally Administered IPG7236 in Healthy Adult Participants
PHASE1
Recruiting
62 participants
Started: Apr 8, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03796962
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
PHASE2
Active, not recruiting
325 participants
Started: Jan 30, 2019 · Completed: Oct 31, 2028
1 condition
2 sponsors
95 locations
NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
PHASE1
Active, not recruiting
272 participants
Started: Sep 20, 2017 · Completed: Dec 31, 2025
13 conditions
2 sponsors
48 locations